Hernán Andreu-Serra

Hernán Andreu-Serra

Auto-generated profile, based on publicly available information

Hernán Andreu-Serra

Department of Digestive Medicine, Son Llàtzer Hospital, Carretera de Manacor, Palma, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
JRJuan B Reinés
Juan B Reinés
TRTomás Ripoll-Vera
Tomás Ripoll-Vera
MMMercedes U Martín
Mercedes U Martín
HSHernán Serra
Hernán Serra
MCMa Margarita C Campins
Ma Margarita C Campins
MCManuel R Cruz
Manuel R Cruz
Transthyretin-associated Familial Amyloid Polyneuropathy (TTR-FAP) is an autosomal dominant disease caused by the deposition of abnormal transthyretin that results from a gene mutation. Although rare worldwide, there are descriptions of several endemic foci, such as in Majorca, Balearic Islands, Spain. We aimed at describing a contemporary series of TTR-FAP patients in Son Llàtzer Hospital in Majorca from an epidemiological point of view in order to report their main clinical and laboratory characteristics.

7 December 2016 in Journal of the Peripheral Nervous System
Verified
Journal Article
Open access
PDF file
JBJuan Buades-Reinés
Juan Buades-Reinés
MRManuel Raya-Cruz
Manuel Raya-Cruz
CGCristina Gallego-Lezaún
Cristina Gallego-Lezaún
TRTomás Ripoll-Vera
Tomás Ripoll-Vera
MUMercedes Usón-Martín
Mercedes Usón-Martín
ECEugenia Cisneros-Barroso
Eugenia Cisneros-Barroso
The age of onset (AO) of hereditary ATTR amyloidosis (hATTR) is known to vary between populations, with differing characteristics reported according to AO in endemic/non‐endemic foci. This was a retrospective study of patients with early AO (<50 years) and late AO (≥50 years) hATTR at our center in Mallorca. Data were collected on patient demographics, clinical disease manifestation, and physical symptoms. A total of 95 patients were analyzed, with mean follow‐up of 9 years from diagnosis. The early AO group included 53 patients (33 male) and the late AO group included 42 patients (21 male). Neurologic involvement was the most common initial symptom, although it was significantly more frequent in the late AO vs. early AO group (p = 0.015). Autonomic involvement was observed in 26% of patients in the early AO group, but was rarely observed in the late AO group (5%). During follow up, cardiologic symptoms, renal involvement, and ophthalmologic symptoms were significantly more common in the late AO group (p < 0.05). This retrospective study demonstrates the variation in disease presentation and progression according to AO of hATTR at our Mallorcan center.